Navigation Links
KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH
Date:11/7/2013

s for the CF indication and has initiated a 180 patient Phase 2 study in CF subjects with chronic Pa lung infection in the United States. KaloBios has received Orphan Drug designation from both the FDA and the European Commission for KB001-A for the treatment of CF patients with Pa lung infection. Sanofi is pursuing a ventilator-associated pneumonia prevention indication in the intensive care setting, an indication which has received U.S. FDA Fast Track Designation.
  • KB004, an anti-EphA3 mAb, has potential in treating hematologic malignancies and solid tumors. KaloBios is currently testing this drug in a Phase 1 study in subjects with hematologic malignancies. KaloBios plans to begin the phase 2 portion of this study in AML and MDS before the end of 2013.
  • All of the company's antibodies were generated using its proprietary Humaneered® technology, a method that converts nonhuman antibodies (typically mouse) into recombinant antibodies that have a high binding affinity to their target and are designed for chronic therapeutic use. The company believes that antibodies produced using its Humaneered® technology offer important clinical and economic advantages over antibodies generated by other methods in terms of high binding affinity, high manufacturing yields, and minimal to no immunogenicity (inappropriate immune response) upon repeat administration in humans.

    For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.

    Forward Looking Statements

    This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including: the statements under the heading "Anticipated Upcoming Milestones for 2013-2014"; and statements regarding the company's clinical development of
    '/>"/>

    SOURCE KaloBios Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology news :

    1. Cell therapy using patients own bone marrow may present option for heart disease
    2. Report presents designs for study of cancer risks near US nuclear facilities
    3. Entomology 2012 to present 105 insect symposia in November
    4. NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards
    5. The Brain Prize 2012 is presented May 9th
    6. Validity CTO to Present Natural ID Solutions for Improving Mobile Risk Management and User Experience at NFC Solutions Summit 2012
    7. John Theurer Cancer Center presents significant blood cancer research at 2012 ASCO Annual Meeting
    8. Amarantus BioSciences to Present at the National Investment Banking Associations (NIBA)122nd Conference in New York City
    9. Coral reef experts to present latest coral reef science during July symposium
    10. FirstMark Exhibiting and Presenting at the San Diego Academy of Family Physicians 55th Annual Postgraduate Symposium
    11. GSA Bulletin presents studies in Antarctica, Italy, Mexico, Algeria, Mongolia, and more
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/23/2015)... LOS ANGELES , March 23, 2015  In ... in Federal fraud case conviction losses. This figure accounts ... fraud, which, according to The Nilson Report, exceeds $11 ... an investigative tool after a crime has occurred. Investor ... Agent and polygraph expert Joe Paolella partnered ...
    (Date:3/20/2015)... 20, 2015 Research and Markets ... the "India Sensors Market Forecast and Opportunities ... The sensor market is projected to grow at ... Consumer electronics, automotive, industrial and healthcare sectors are ... country. In addition, adoption of MEMS technology in ...
    (Date:3/20/2015)... , March 20, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... is one of the products featured in 2015 "I ... at 11:00 PM EST on the DIY Network.   ... Las Vegas , site of the 2015 ...
    Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
    ... CITY)Vision scientists long have thought that lack of very long ... with Stargardt type 3 retinal degeneration, an incurable eye disease. ... Eye Center have shown in a new study that lack ... the search for the mechanism that robs sight from children ...
    ... sign of continuing evolution in the college textbook market, ... industry leader (NYSE:JWa, JWb), and Rice University-based OpenStax College, ... The partnership calls for Wiley to deliver content from ... its online learning, practice and assessment resources that ...
    ... can change DNA topology, making DNA twist up into a so-called ... of the proteinknown as mini-chromosome maintenance (MCM)in cancer cells, which have ... of a rubber band while holding the other end still. After ... you keep on turning, the twisted band will twist back upon ...
    Cached Biology News:Long-suspected cause of blindness from eye disease disproved 2Unlikely partners create innovative product for college biology 2Protein abundant in cancerous cells causes DNA 'supercoiling' 2
    (Date:4/1/2015)... and NEW YORK CITY and ... a leading provider of market research reports and solutions, MarketResearch.com ... indicating that 2015 will be a year of market growth ... executives operating a stem cell company or cord blood bank, ... You must analyze market conditions, predict industry trends, and act ...
    (Date:3/31/2015)... -- CytoSorbents Corporation (NASDAQ CM: CTSO), a critical ... critically-ill and cardiac surgery patients in multiple countries ... results for the fiscal year ending December 31, ... were a record $3.1M, an increase of $2.3M ... $0.8M Highlights for the Year Ending December 31, ...
    (Date:3/31/2015)... 2015 Pittcon 2015, the 66th Conference ... on March 12, in New Orleans with an economic ... estimated by the New Orleans Convention and Visitor's Bureau. ... and exhibitor personnel. Those who attended Pittcon for ... For the third year, the co-location of Food Labs ...
    (Date:3/31/2015)... YORK , March 31, 2015  PlasmaTech ... company advancing protein biologic therapies and oncology supportive ... partner, Hanmi Pharmaceutical Co., Ltd ("Hanmi") (KSE: 128940) ... country,s Ministry of Food and Drug Safety ("MFDS") ... for MuGard, its oncology supportive-care treatment for the ...
    Breaking Biology Technology:MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4CytoSorbents Reports Record 2014 Revenue 2CytoSorbents Reports Record 2014 Revenue 3CytoSorbents Reports Record 2014 Revenue 4CytoSorbents Reports Record 2014 Revenue 5CytoSorbents Reports Record 2014 Revenue 6CytoSorbents Reports Record 2014 Revenue 7CytoSorbents Reports Record 2014 Revenue 8CytoSorbents Reports Record 2014 Revenue 9CytoSorbents Reports Record 2014 Revenue 10CytoSorbents Reports Record 2014 Revenue 11Pittcon 2015 Hits the Big Easy in a Big Way 2Pittcon 2015 Hits the Big Easy in a Big Way 3Pittcon 2015 Hits the Big Easy in a Big Way 4PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3
    ... Solve and Prevent Crimes, CARLSBAD, N.M., April 17 ... the efforts of US Attorney General,Michael Mukasey in bringing ... DNA testing provisions enacted by Congress in,late 2005. These ... in their own states. The federal law requires a ...
    ... that it will build a new biotech research & ... early-stage evaluation of GM and,native traits for key crops ... yield,improvement, drought resistance, disease control and biomass conversion for,biofuels. ... will complement,Syngenta,s biotech research activities in the US. The ...
    ... As nanotechnology has moved out of the laboratory and ... impact of nanoscale materials on health and the environment. ... daunting task, given the number of potential products, the ... and leverage costs toward a more efficient, timely international ...
    Cached Biology Technology:Mothers of Victims Applaud Federal Effort to Collect DNA Upon Arrest 2Syngenta To Build Major Global Biotech Research Center in Beijing, China 2Syngenta To Build Major Global Biotech Research Center in Beijing, China 3International Council on Nanotechnology launches global research needs assessment 2